Salomon et al developed a score for predicting seminal vesicle invasion in a patient with prostate cancer that is clinically localized. This can help decide between therapeutic alternatives and can aid with informed consent. The authors are from Henri Mondor and Saint-Louis Hospitals in France and Columbia University in New York City.